KAS attended and exhibited at the AAPS PharrmSci 360 conference in Salt Lake City, UT October 20 – 23, 2024 this year. During the annual meeting, Drs. Hanrahan and Nethercott from KAS presented on four separate posters highlighting the advances of solid-state NMR spectroscopy in the pharmaceutical industry. Two of the posters were collaborations with other groups, highlighting solid-state NMR as an advanced analytical technique, which can be utilized as an orthogonal path for sample analysis. One poster was highlighting KAS’s commitment to performing solid-state NMR spectroscopy on high potency samples in a safe and controlled manner (insert reference to BAND 5 blog post). The final poster was a coloration with USP to develop a potential new chapter on solid-state NMR for the general pharmaceutical community.
AAPS is an annual meeting for the pharmaceutical industry that routinely draws over 5,000 people from around the world to see the latest cutting edge research in the pharmaceutical industry. KAS is a leading supplier of GMP solid-state NMR spectroscopy for the pharmaceutical industry. KAS is an FDA registered lab, and also holds a valid DEA license for the analysis of Controlled substances (cross link to DEA license press release). Contact us today to discuss your project and how we can support you with solid-state NMR spectroscopy. (Cross link to our 2 page handout on capabilities, see attached pdf).
Poster References:
- (M1530-11-63) Safe and Effective Analysis of High Potency Compounds Using Solid-State NMR Spectroscopy
- (T1530-11-63) Development of the USP Chapter < 1762 > for Solid-State Nuclear Magnetic Resonance Spectroscopy
- (W1230-07-41) Novel Inter-Polymer Complexes in the Development of Spray-Dried Dispersions: A Computational and Experimental Study
- (T1430-03-18) Balancing Particle Stability and Permeability Advantages of High Drug Loading Amorphous Nanoparticle Formulations
